[Autoimmune reactions and paraneoplastic syndromes]

Area of Science:

• Neurology
• Immunology
• Radiology

Background:

• Central nervous system (CNS) autoimmune disorders are a diverse group, including multiple sclerosis (MS), clinically isolated syndrome (CIS), acute demyelinating encephalomyelitis (ADEM), and neuromyelitis optica spectrum disorders (NMOSD).
• Paraneoplastic syndromes are rare, tumor-associated conditions caused by autoantibodies targeting CNS proteins, distinct from direct tumor invasion.

Purpose of the Study:

• To highlight the diagnostic challenges in autoimmune and paraneoplastic CNS disorders.
• To emphasize the role of magnetic resonance imaging (MRI) in diagnosis and monitoring.
• To underscore the importance of laboratory tests in paraneoplastic syndrome diagnosis.

Main Methods:

• Review of diagnostic approaches for CNS autoimmune and paraneoplastic syndromes.
• Integration of patient history, clinical examination, blood tests, cerebrospinal fluid (CSF) analysis, and MRI.
• Utilizing MRI for initial diagnosis, follow-up, and therapy monitoring, including early detection of complications like progressive multifocal leukoencephalopathy (PML).

Main Results:

• Accurate diagnosis of these heterogeneous CNS disorders remains challenging.
• MRI is increasingly vital for diagnosis, follow-up, and monitoring of conditions like MS.
• MRI findings in paraneoplastic syndromes may be delayed, necessitating follow-up scans.

Conclusions:

• Laboratory tests for specific autoantibodies in serum and CSF are fundamental for diagnosing paraneoplastic syndromes.
• Treatment strategies vary, including steroids, immunosuppressants, and plasmapheresis, tailored to the specific disorder.